NFA
ABBV icon

Northwest Financial Advisors’s AbbVie ABBV Stock Holding History

Northwest Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,233
Closed -$677K – 96
2025
Q1 		$677K Buy
3,233
+18
+0.6% +$3.5K 0.56% 45
2024
Q4 		$571K Buy
3,215
+20
+0.6% +$3.68K 0.47% 52
2024
Q3 		$631K Buy
3,195
+17
+0.5% +$3.17K 0.5% 46
2024
Q2 		$545K Buy
3,178
+20
+0.6% +$3.31K 0.55% 47
2024
Q1 		$575K Buy
3,158
+18
+0.6% +$3.1K 0.63% 43
2023
Q4 		$487K Buy
+3,140
New +$458K 0.41% 47

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Northwest Financial Advisors's ABBV Position: Q2 2025 in Review

Northwest Financial Advisors sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 3,233 shares — an estimated $677K sold.

Northwest Financial Advisors first reported a position in ABBV in Q4 2023 and held it in 6 quarters. The position peaked at $677K in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Northwest Financial Advisors reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Northwest Financial Advisors sold 3,233 AbbVie shares in Q2 2025, an estimated $677K.
  • Northwest Financial Advisors first reported a position in AbbVie in Q4 2023 and held it in 6 quarters.
  • Northwest Financial Advisors's AbbVie position peaked at $677K in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Northwest Financial Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.